This article is more than 5 years old. Information may no longer be current.

VIDEO: Cataract surgery safe in patients undergoing aflibercept therapy for DME

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAN FRANCISCO — At the American Society of Retina Specialists meeting here, OSN Retina/Vitreous Section Editor Andrew A. Moshfeghi, MD, MBA, of the USC Roski Eye Institute, discusses a study that found no impact on visual outcomes and nominal central retinal thickness gains when patients on aflibercept therapy for diabetic macular edema underwent cataract surgery.